Recent Publications

Lal K, Morrell TJ, Cunningham M, O’Donnell P, Levin NA, Cornejo KM. A case of a malignant cutaneous mixed tumor (chondroid syringomas) of the scapula treated with staged margin-controlled excision. Am J Dermatopathol 2018;40:679-81. 

Petkiewicz S, Baltz J, Cornejo K, Deng A, Wiss K. Widespread presentation and spontaneous regression of porokeratotic eccrine ostial and dermal duct nevus. JAAD Case Rep 2018;4:972-5.

Feinstein JA, Jambal P, Peoples K, Lucky A, Khuu P, Tang JY, Lara-Corrales I, Pope E, Wiss K, et al. Assessment of the timing of milestone clinical events in patients with epidermolysis bullosa from North America. JAMA Dermatol 2018;epub ahead of print 12/26/2018.

 Van Geel N, Wolkerstorfer A, Lommerts JE, Ezzedine K, Eleftheriadou V, Hamzavi I, Harris J, Picardo M, Taieb A, Prinsen CA, Bekkenk M, and Speeckaert R. Validation study of the vitiligo extent core-plus (VESplus). J Am Acad Derm 2018;78:1013-5.

Korta DZ, Christiano AM, Bergfeld W, Duvic M, Ellison A, Fu J, Harris JE, Hordinsky MK, King B, Kranz D, Mackay-Wiggan J, McMichael A, Norris DA, Price V, Shapiro J, and Atanaskova-Mesinkovska N. Alopecia areata is a medical disease. J Am Acad Derm 2018;78: 832-4.

Van Geel N, Bekkenk M, Lommerts JE, Ezzedine K, Harris J, Hamzavi I, Eleftheriadou V, Picardo M, Taieb A, Prinsen C, Wolkerstorfer A, and Speeckaert R. The Vitiligo Extent Score (VES) and the VESplus are responsive instruments to assess global and regional treatment response in patients with vitiligo. J Am Acad Derm 2018; ePub ahead of print.

Mande P, Zirak B, Ko WC, Taravati K, Bride KL, Brodeur TY, Deng A, Dresser K, Jiang Z, Ettinger R, Fitzgerald KA, Rosenblum MD, Harris JE, and Marshak-Rothstein A. Fas ligand promotes an inducible TLR-dependent model of cutaneous lupus-like inflammation. J Clin Invest 2018; ePub ahead of print.

 Rork JF, Prindaville B, Dalla Costa R, Wiss K. Response to “Doing the math: A simple approach to topical timolol dosing for infantile hemangiomas”. Pediatr Dermatol 2018;35:700

 Winkler A, Prindaville B, Wiss K. Curvilinear erythematous plantar patch in a toddler. Pediatr Dermatol 2018;35:251-2.

Dalla Costa R, Prindaville B, Wiss K. Doing the math: A simple approach to topical timolol dosing for infantile hemangiomas. Pediatric Dermatol 2018;35:276-7.

McDermott LE, Midura M, Papagermanos V, Kirby J, Wanat KA, Belazarian LT, Dunnick C, Mounessa JS, Savory SA, Avashia-Khemka N, Strunk A, Garg A. Satisfaction with care and likelihood to recommend ratings attributed to dermatology trainees. J Am Acad Dermatol 2018;78:610-2.

Prindaville B, Belazarian L, Levin NA, Wiss K. Pityrosporum folliculitis: A retrospective review of 110 cases. J Am Acad Dermatol 2018;78:511-4.

Richmond J, Strassner JP, Zapata L Jr., Garg M, Riding RL, Refat MA, Fan X, Azzolino V, Tovar-Garza A, Tsurushita N, Pandya AG, Tso JY, and Harris JE. Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo. Science Transl Med 2018;10:1-9.

Droms RJ, Snadecki H, Deng A, Levin NA. Lichen planus pigmentosus in a blaschkoid distribution. Dermatol Online J 2017;23 (6).

Krueger S, Rork J, Lee J, Cornejo K, Gibson L, Daly JS, Levin NA. Mycobacterium haemophilum infection in a renal transplant patient with inflammatory bowel disease. Dermatol Online J 2017;23(9).

Li AW, Prindaville B, Bateman ST, Gibson TE, Wiss K. Inpatient management of children with recessive dystrophic epidermolysis bullosa: A review. Pediatr Dermatol 2017;34:647-55.

Kane J, Berrebi K, McLean R, Petkiewicz S, Hay B, Martin M, Wiss K. Noonan syndrome with loose anagen hair associated with trichorrhexis nodosa and trichoptilosis. Clin Case Rep 2017;5:1152-4.

Bronckers IMGJ, Seyger MMB, West DP, Lara-Corrales I, Tollefson M, Tom WL, Hogeling M, Belazarian L, Zachariae C, Mahé E, Siegfried E, Philipp S, Szalai Z, Vleugels RA, Holland K, Murphy R, Baselga E, Cordoro K, Lambert J, Alexopoulos A, Mrowietz U, Kievit W, Paller AS; Psoriasis Investigator Group (PsIG) of the Pediatric Dermatology Research Alliance and the European Working Group on Pediatric Psoriasis (EWGPP). Safety of systemic agents for the treatment of pediatric psoriasis. JAMA Dermatol 2017;153:1147-57.

Droms RJ, Rork JF, McLean R, Martin M, Belazarian L, Wiss K. Menkes disease mimicking child abuse. Pediatr Dermatol 2017;34:e132-4.

Gan EY, Eleftheriadou V, Esmat S, Hamzavi I, Passeron T, Böhm M, Anbar T, Goh BK, Lan CE, Lui H, Ramam M, Raboobee N, Katayama I, Suzuki T, Parsad D, Seth V, Lim HW, van Geel N, Mulekar S, Harris J, Wittal R, Benzekri L, Gauthier Y, Kumarasinghe P, Thng ST, Silva de Castro CC, Abdallah M, Vrijman C, Bekkenk M, Seneschal J, Pandya AG, Ezzedine K, Picardo M, Taïeb A; VGICC. Repigmentation in vitiligo: position paper of the Vitiligo Global Issues Consensus Conference (VGICC). Pigment Cell & Melanoma Research. 2017;30: 28-40.

Richmond JM, Essien KI, BangariDS, CurrimbhoySD, GroomJR, PandyaAG, YoudME, LusterAD, HarrisJE. Keratinocyte-derived chemokines orchestrate T cell positioning in the epidermis during vitiligo and may serve as biomarkers of disease. J Invest Dermatol 2017;137: 350-8.

Richmond JM, Masterjohn E, Chu R, Tedstone J, YoudME, HarrisJE. CXCR3 depleting antibodies prevent and reverse vitiligo in mice. J Invest Dermatol 2017;137: 982-5.

Mohammad TF, Al-Jamal M, Hamzavi IH, Harris JE, Leone G, Cabrera R, Lim HW, Pandya AG, and Esmat SM. The Vitiligo Working Group recommendations for narrowband ultraviolet B treatment of vitiligo. J Am Acad Dermatol 2017;76: 879-88.

Strassner J, Rashighi M, Refat MA, Richmond JM, and Harris JE. Suction blistering the lesional skin of vitiligo patients reveals useful biomarkers of disease activity. J Am Acad Dermatol 2017;76: 847-55.

Van Geel N, Boniface K, Seneschal J, Jacquemin C, Speeckaert R, Wolkerstorfer  A, Bekkenk M, Lommerts JE, Hamzavi I, Pandya A, Eleftheriadou V, Ezzedine K, Giannarelli D, Gnarra M, Sperduti I, Prinsen C, Harris J, Taieb A, Picardo M. Meeting report: Vitiligo Global Issues Consensus Conference (VGICC) Workshop "Outcome measurement instruments" and Vitiligo International Symposium, Rome, Nov 30-Dec 3rd. Pigment Cell & Melanoma Research. 2017;30:436-43.

Liu LY, Strassner JP, Refat MA, Harris JE*, and King BA*. Repigmentation in vitiligo using the janus kinase inhibitor, tofacitinib, requires concomitant light exposure. J Am Acad Dermatol 2017; 77: 675-82.

Vanderweil SG, Amano SU, Ko W, Richmond JM, Rashighi M, Kelley M, Makredes-Senna M, Pearson A, Chowdary S, Hartigan C, Barton B, Harris JE. A double-blind, placebo-controlled, phase-II clinical trial to evaluate oral simvastatin as a treatment for vitiligo. J Amer Acad Dermatol 2017;76:150-1.  

Auerbach A, Mulvaney P, Goldberg D, Foley E, Maloney M. Single-cell squamous carcinoma: An underreported high-risk variant. Dermatol Surg 2016;42:S2-7.

Tang N, Maloney ME, Clark AH, Jellinek NJ. A retrospective study of nail squamous cell carcinoma at 2 institutions. Dermatol Surg 2016;42:S8-17.  

St John J, Walker J, Goldberg D, Maloney ME. Avoiding medical errors in cutaneous site identification: A best practices review. Dermatol Surg 2016;42:477-84.

 ucher EF, Kim A, Givan J, Maloney ME. Dermatologic surgery on the chest wall in patients with a cardiac surgery history: a review of material that may be encountered intraoperatively, including potential complications and suggestions for proceeding safely. Int J Women’s Dermatol 2016;2:13-17.

Javorsky E, Perkins A, Scharf MJ. Resolution of disseminated granuloma annulare with removal of surgical hardware. Cutis 2016;98:E10-1.

St John J, Summe H, Csikesz C, Wiss K, Hay B, Belazarian L. Multiple café au lait spots in a group of fair-skinned children without signs or symptoms of neurofibromatosis Type 1.Pediatr Dermatol 2016;33:526-9.

Li JLY, Lim CH, Tay FW, Goh CC, Devi S, Malleret B, Lee B, Bakocevic N, Chong SZ, Evrard M, Tanizaki H, Lim HY, Russell B, Renia L, Zolezzi F, Poidinger M, Angeli V, St. John AL, Harris JE, Tey HL, Tan SM, Kabashima K, Weninger W, Larbi A, Ng LG. Neutrophils self-regulate immune complex-mediated cutaneous inflammation through CXCL2. J Invest Dermatol 2016;136:416-24.

Harris JE, Rashighi M, Nguyen N, Jabbari A, Clynes R, Christiano AM, Mackay-Wiggan J. Rapid skin repigmentation on oral ruxolitinib in a patient with coexistent vitiligo and alopecia areata. J Am Acad Dermatol 2016;74:370-1.

Chong SZ, Evrard M, Devi S, Zhang Y, Tan L, Li JLY, Tan SM, Chan JKY, Balabanian K, Harris JE, Chen Q, RéniaL, Wang CI, Larbi A, Looney MR, Krummel MF, Randolph GJ, Ginhoux F, Hidalgo A, Bachelerie F, Ng LG. CXCR4 identifies transitional bone marrow premonocytes that replenish the mature monocyte pool for peripheral responses. J Exp Med 2016; 213(11): 2293-2314.

Vanderweil SG, Amano S, Ko W, Richmond JM, Kelley M, Makredes Senna M, Pearson A, Chowdary S, Hartigan C, Barton B, Harris JE. A double-blind, placebo-controlled, phase-II clinical trial to evaluate oral simvastatin as a treatment for vitiligo. J Am Acad Dermatol 2016; 76:150-1.

Cohen JL, Shen Y, Aouadi M, Vangala P, Tencerova M, Amano SU, Nicoloro SM, Yawe JC, Czech MP. “Peptide- and amine-modified glucan particles for the delivery of therapeutic siRNA.” Acs.molpharmaceut 2016;13:964-78.